Accurate, Focused Research on Law, Technology and Knowledge Discovery Since 2002

Coalition Demands FDA Deny Approval Of Controversial Genetically Engineered Fish

News release: “A coalition of 31 consumer, animal welfare and environmental groups, along with commercial and recreational fisheries associations and food retailers submitted a joint statement criticizing an announcement this week by the U.S. Food and Drug Administration (FDA) that it will potentially approve the long-shelved AquAdvantage transgenic salmon as the first genetically engineered (GE) animal intended for human consumption. The engineered Atlantic salmon being considered was developed by AquaBounty Technologies, which artificially combined growth hormone genes from an unrelated Pacific salmon, (Oncorhynchus tshawytscha) with DNA from the anti-freeze genes of an eelpout (Zoarces americanus). This modification causes production of growth-hormone year-round, creating a fish the company claims grows at twice the normal rate. This could allow factory fish farms to crowd fish into pens and still get high production rates.”

  • Public Still In The Dark On Transgenic Salmon: “A broad coalition of consumer and environmental groups, along with community fishing organizations and food retailers, declared today’s partial data release by the U.S. Food and Drug Administration (FDA) on the genetically engineered salmon up for approval as a human food product insufficient and unacceptable…In a letter sent {September 3, 2010] to FDA Principle Deputy Commissioner Joshua Sharfstein, Rep. Dennis Kucinich called on FDA to slow down its process and ensure that the public has sufficient time and all available data to provide meaningful and informed public comment. The letter requests FDA delay its public meetings by 30 days as well as provide a 90-day public comment period, currently absent from the GE salmon approval process. Rep. Kucinich is the Chairman of the House Domestic Policy Subcommittee, which has broad jurisdiction over many federal agencies, including FDA.”
  • Sorry, comments are closed for this post.